Outcome of continence procedures after failed endoscopic treatment with dextranomer-based implants (DEFLUX®)

Alova, Ilona; Margaryan, M.; Verkarre, V.; Bernuy, M.; Jacob, S.; Lottmann, Henri

doi:10.1016/j.jpurol.2010.12.002

Cited by 17 publications

(14 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While some might be concerned about the potential effect of a previously injected bulking agent on a later open revision, several authors mention that surgery at the bladder neck or Mitrofanoff after endoscopic injection of Dx/HA was not considered more difficult than in noninjected patients. 18,20 With up to 8 years follow-up, our results reveal a success rate of 86%. We also demonstrated that some patients might benefit from a repeated injection, with most of our patient population being completely continent on the first two sessions.…”

Section: Mitrofanoff Injectionmentioning

confidence: 55%

Endoscopic Treatment with Dextranomer/Hyaluronic Acid for Persistent Incontinence After Continent Urinary Reconstruction

Riachy

DeFoor

Reddy

et al. 2015

Journal of Endourology

View full text Add to dashboard Cite

show abstract

Section: Mitrofanoff Injectionmentioning

confidence: 55%

Endoscopic Treatment with Dextranomer/Hyaluronic Acid for Persistent Incontinence After Continent Urinary Reconstruction

Riachy

DeFoor

Reddy

et al. 2015

Journal of Endourology

View full text Add to dashboard Cite

show abstract

“…11 In the present series 12 patients underwent bladder neck surgery after failed endoscopic injection without difficulty. All 10 implanted continence devices are in place, no erosion or infection has been observed and 11 of 12 patients are dry.…”

Section: Discussionmentioning

confidence: 73%

“…Of these patients 35 (41%) were dry, 16 (19%) were significantly improved and 34 (40%) were classified as treatment failures. 11 The current study focuses on the long-term results of endoscopic treatment of incontinence within the subgroup of patients treated for neurogenic incontinence and attempts to define criteria predictive of success or failure.…”

mentioning

confidence: 99%

Long-Term Effects of Endoscopic Injection of Dextranomer/Hyaluronic Acid Based Implants for Treatment of Urinary Incontinence in Children with Neurogenic Bladder

Alova¹,

Margaryan

Bernuy³

et al. 2012

Journal of Urology

View full text Add to dashboard Cite

show abstract

“…Bulking agents have demonstrated a low success rate (10‐40%), which is only temporary in most cases . On the other hand, bulking agents at the level of the bladder outlet have shown not to adversely affect the outcome of further definitive surgical procedures . Bladder neck closure with a continent catheterizable stoma is often seen as the last resort to gain urinary continence in those patients with persistent urinary incontinence .…”

Section: Procedures To Increase the Bladder Outlet Resistancementioning

confidence: 99%

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management

Stein

Bogaert

Doğan

et al. 2019

Neurourology and Urodynamics

View full text Add to dashboard Cite

Background: Treatment in children and adolescents with a neurogenic bladder is primarily conservative with the goal of preserving the upper urinary tract combined with a good reservoir function of the bladder. However, sometimeseven in childhood-conservative management does not prevent the development of a low-compliant bladder or overactive detrusor. Material & Methods: After a systematic literature review covering the period 2000-2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update.Results: In these patients, surgical interventions such as botulinum toxin A injections into the detrusor muscle, bladder augmentation, and even urinary diversion may become necessary to preserve the function of the upper (and lower) urinary tracts. The creation of a continent catheterizable channel should be offered to patients with difficulties performing transurethral clean intermittent catheterization. However, a revision rate of up to 50% needs to be considered. With increasing age continence of urine and stool becomes progressively more important. In patients with persistent weak bladder outlets, complete continence can be achieved only by surgical interventions creating a higher resistance/obstruction at the level of the bladder outlet with a success rate of up to 80%. In some patients, bladder neck closure and the creation of a continent catheterizable stoma is an option. Conclusion:In all these patients close follow-up is mandatory to detect surgical complications and metabolic consequences early. K E Y W O R D Sbladder augmentation, bladder neck reconstruction, EAU guideline, Mitrofanoff stoma, neurogenic bladder, sling procedure, urinary diversion

show abstract

Outcome of continence procedures after failed endoscopic treatment with dextranomer-based implants (DEFLUX®)

Cited by 17 publications

References 20 publications

Endoscopic Treatment with Dextranomer/Hyaluronic Acid for Persistent Incontinence After Continent Urinary Reconstruction

Endoscopic Treatment with Dextranomer/Hyaluronic Acid for Persistent Incontinence After Continent Urinary Reconstruction

Long-Term Effects of Endoscopic Injection of Dextranomer/Hyaluronic Acid Based Implants for Treatment of Urinary Incontinence in Children with Neurogenic Bladder

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management

Contact Info

Product

Resources

About